Literature DB >> 9401081

Analysis of p18INK4C in adult T-cell leukaemia and non-Hodgkin's lymphoma.

Y Hatta1, K Spirin, T Tasaka, R Morosetti, J W Said, Y Yamada, M Tomonaga, H P Koeffler.   

Abstract

p18INK4C, a cyclin-dependent kinase inhibitor, is a homologue of p15INK4B and p16INK4A which are frequently altered in a variety of malignancies. We searched for structural alterations of the p18INK4C gene in 44 adult T-cell leukaemias (ATLs), 101 non-Hodgkin's lymphomas (NHLs), two polyclonal B-cell proliferations, seven ATL cell lines and seven leukaemia/lymphoma cell lines, by Southern blot and polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analyses. No genomic alterations of the p18INK4C gene were found in any of the samples. By RT-PCR, p18INK4C was not expressed in three of five ATL cell lines, whereas it was expressed in all the non-ATL leukaemia/lymphoma cell lines. Tax did not inhibit the expression of p18INK4C in tax-expressing Jurkat cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401081     DOI: 10.1046/j.1365-2141.1997.4333243.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.

Authors:  E Latres; M Malumbres; R Sotillo; J Martín; S Ortega; J Martín-Caballero; J M Flores; C Cordón-Cardo; M Barbacid
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective.

Authors:  Nishat Aliya; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Leuk Res Treatment       Date:  2012-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.